Connect with us


Novartis Sells Off Eye Health Drug

Eyevance bought the product.




FORT WORTH, TX — Eyevance Pharmaceuticals has acquired of Flarex 0.1% from Novartis AG.

Financial terms of the deal were not disclosed.

Flarex (fluorometholone acetate ophthalmic suspension), approved in the U.S., is indicated for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the eye, according to a press release.

“The acquisition of FLAREX escalates Eyevance’s mission to service important needs in the eye care market,” said Jerry St. Peter, CEO and director of Eyevance. “With over 9 million corticosteroids prescribed annually, at a compounded annual growth rate (CAGR) of 3.1% over the past five years, this large and invaluable therapeutic category provides Eyevance a tremendous opportunity with FLAREX. Corticosteroids are very important options for clinicians when treating ocular inflammation; FLAREX is a proven, well-accepted treatment for multiple ocular inflammatory conditions. Accordingly, it will become a valuable addition to our existing product portfolio, which includes several impactful products for conditions of the anterior segment.”

The purchase of Flarex “marks another important milestone for the Eyevance team,” according to the release. Eyevance’s portfolio consists of Zerviate cetirizine ophthalmic suspension 0.24% (licensed in September 2017 from Nicox Ophthalmics), FreshKote Preservative Free Tear Lubricant line (acquired in September 2018 from Focus Laboratories), and Nexagon (licensed in October 2018 from OcuNexus).


Since launching in 2014, INVISION has won 23 international journalism awards for its publication and website. Contact INVISION's editors at


Crizal® Sapphire™ HR: Invisible Shield of Protection

Your patients’ main concerns of anti-glare, scratch resistance, and easiness to clean are covered. Crizal Sapphire HR, the latest and most advanced product in the Crizal No-Glare range, is now widely available across lab networks and through all major managed vision care providers. Crizal Sapphire HR is available with Essilor’s advanced lens designs such as Varilux® progressive lenses and Eyezen® enhanced single vision lenses. Click here to learn more. *External laboratory tests and internal technical tests – 2020. Compared to the competitor most known lens-brands by consumers (2019 external brand tracking in 11 countries). The word ’overall’ refers to anti-reflective coatings important criteria, ranked through an external quantitative consumer study – 2019.

Promoted Headlines





Get the most important news and business ideas for eyecare professionals every weekday from INVISION.



Most Popular